<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31792674</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>268</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Retinal changes in amyotrophic lateral sclerosis: looking at the disease through a new window.</ArticleTitle><Pagination><StartPage>2083</StartPage><EndPage>2089</EndPage><MedlinePgn>2083-2089</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-019-09654-w</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is the most frequent degenerative disease affecting motor neurons (MN). ALS has been traditionally considered as a pure motor system disease; however, there are currently sufficient evidences supporting the involvement of other non-motor systems. Recently, the development and the implementation of the optical coherence tomography (OCT) have provided new data regarding the ocular involvement in the disease. In this sense, alterations in retinal nerve fiber layer thickness (RNFL), other retinal layers thicknesses such as outer nuclear layer (ONL) and inner nuclear layer (INL) and changes in the retinal blood vessels have been described in ALS patients. Interestingly, the study of ocular alterations in ALS appears not only as new biomarker tool, but also as a new opportunity to deep into the pathogenesis of the disease. In this article we will review and standardize published studies regarding OCT and ALS, emphasizing both their strengths and weaknesses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cerver&#xf3;</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Hospital Universitario Marqu&#xe9;s de Valdecilla-IDIVAL, Santander, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Casado</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Hospital Universitario Marqu&#xe9;s de Valdecilla-IDIVAL, Santander, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Riancho</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service of Neurology, Hospital Sierrallana-IDIVAL, Barrio Ganzo, s/n, 39300, Torrelavega, Cantabria, Spain. javier.riancho86@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERNED, Madrid, Spain. javier.riancho86@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012160" MajorTopicYN="N">Retina</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012171" MajorTopicYN="N">Retinal Vessels</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Optical coherence tomography</Keyword><Keyword MajorTopicYN="N">Retinal blood vessels</Keyword><Keyword MajorTopicYN="N">Retinal nerve fiber layer</Keyword><Keyword MajorTopicYN="N">Retinal thickness</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31792674</ArticleId><ArticleId IdType="doi">10.1007/s00415-019-09654-w</ArticleId><ArticleId IdType="pii">10.1007/s00415-019-09654-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Riancho J, Lozano-Cuesta P, Santurtun A, Sanchez-Juan P, Lopez-Vega JM, Berciano J et al (2016) Amyotrophic lateral sclerosis in northern Spain 40 years later: what has changed? Neurodegener Dis 16(5&#x2013;6):337&#x2013;341</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000445750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufiria M, Gil-Bea FJ, Fernandez-Torron R, Poza JJ, Munoz-Blanco JL, Rojas-Garcia R et al (2016) ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol 142:104&#x2013;129</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.05.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Bosque-Varela P, Perez-Pereda S, Povedano M, de Munain AL, Santurtun A (2018) The increasing importance of environmental conditions in amyotrophic lateral sclerosis. Int J Biometeorol 62(8):1361&#x2013;1374</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00484-018-1550-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Gil-Bea FJ, Santurtun A, Lopez DM (2019) Amyotrophic lateral sclerosis: a complex syndrome that needs an integrated research approach. Neural Regener Res 14(2):193&#x2013;196</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.244783</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoon M, Okawa H, Della SL, Wong RO (2014) Functional architecture of the retina: development and disease. Prog Retin Eye Res 42:44&#x2013;84</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preteyeres.2014.06.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Wang H, Fan D, Wang W (2018) Comparison of optical coherence tomography findings and visual field changes in patients with primary open-angle glaucoma and amyotrophic lateral sclerosis. J Clin Neurosci 48:233&#x2013;237</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2017.10.080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringelstein M, Albrecht P, Sudmeyer M, Harmel J, Muller AK, Keser N et al (2014) Subtle retinal pathology in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 1(4):290&#x2013;297</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.46</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubers A, Muller HP, Dreyhaupt J, Bohm K, Lauda F, Tumani H et al (2016) Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging. J Neural Transm (Vienna ) 123(3):281&#x2013;287</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-015-1483-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonett JM, Huang R, Siddique N, Farsiu S, Siddique T, Volpe NJ et al (2016) Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci Rep 6:29187</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep29187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee N, McBurney-Lin S, Kuo A, Bedlack R, Tseng H (2017) Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease. PLoS ONE 12(9):e0185242</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185242</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohani M, Meysamie A, Zamani B, Sowlat MM, Akhoundi FH (2018) Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression. J Neurol 265(7):1557&#x2013;1562</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8863-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhak A, Hubers A, Bohm K, Ludolph AC, Kassubek J, Pinkhardt EH (2018) In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis. J Neurol 265(4):949&#x2013;953</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8787-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth NM, Saidha S, Zimmermann H, Brandt AU, Oberwahrenbrock T, Maragakis NJ et al (2013) Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol 20(8):1170&#x2013;1176</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12146</ArticleId></ArticleIdList></Reference><Reference><Citation>Maresca A, la Morgia C, Caporali L, Valentino ML, Carelli V (2013) The optic nerve: a "mito-window" on mitochondrial neurodegeneration. Mol Cell Neurosci 55:62&#x2013;76</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2012.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436&#x2013;1441</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth RP, Atkin JD (2018) Dysfunction of optineurin in amyotrophic lateral sclerosis and glaucoma. Front Immunol 9:1017</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01017</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Gonzalo I, Ruiz-Soto M, Berciano J (2019) Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis. Neurologia 34(1):27&#x2013;37</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2015.12.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P et al (2007) Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry 78(7):754&#x2013;756</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.109553</ArticleId></ArticleIdList></Reference><Reference><Citation>Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M (2017) Optical coherence tomography in Alzheimer's disease and other neurodegenerative diseases. Front Neurol 8:701</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrysou A, Jansonius NM, van Laar T (2019) Retinal layers in Parkinson's disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord 64:40&#x2013;49</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2019.04.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Manogaran P, Hanson JV, Olbert ED, Egger C, Wicki C, Gerth-Kahlert C et al (2016) Optical coherence tomography and magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder. Int J Mol Sci 17(11):1894</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17111894</ArticleId></ArticleIdList></Reference><Reference><Citation>Eraslan M, Balci SY, Cerman E, Temel A, Suer D, Elmaci NT (2016) Comparison of optical coherence tomography findings in patients with primary open-angle glaucoma and Parkinson disease. J Glaucoma 25(7):e639&#x2013;e646</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IJG.0000000000000239</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss HE, McCluskey L, Elman L, Hoskins K, Talman L, Grossman M et al (2012) Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci 314(1&#x2013;2):97&#x2013;101</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.10.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Casado A, Cervero A, Lopez-de-Eguileta A, Fernandez R, Fonseca S, Gonzalez JC et al (2019) Topographic correlation and asymmetry analysis of ganglion cell layer thinning and the retinal nerve fiber layer with localized visual field defects. PLoS ONE 14(9):e0222347</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0222347</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-de-Eguileta A, Lage C, Lopez-Garcia S, Pozueta A, Garcia-Martinez M, Kazimierczak M et al (2019) Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET. Alzheimers Dement (NY) 5:570&#x2013;578</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2019.08.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera DD, Somfai GM, Koller A (2017) Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases. Am J Physiol Heart Circ Physiol 312(2):H201&#x2013;H212</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00201.2016</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew G, Wang JJ, Mitchell P, Wong TY (2008) Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging 1(2):156&#x2013;161</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.108.784876</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley AF, Bossen EH (2013) Skeletal muscle microvasculature in the diagnosis of neuromuscular disease. J Neuropathol Exp Neurol 72(10):906&#x2013;918</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182a7f0b8</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolde G, Bachus R, Ludolph AC (1996) Skin involvement in amyotrophic lateral sclerosis. Lancet 347(9010):1226&#x2013;1227</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)90737-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulut M, Kurtulus F, Gozkaya O, Erol MK, Cengiz A, Akidan M et al (2018) Evaluation of optical coherence tomography angiographic findings in Alzheimer's type dementia. Br J Ophthalmol 102(2):233&#x2013;237</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2017-310476</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>